Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, >130-fold selectivity for JAK1/2 versus JAK3.
| Quantity | 500 mg, 1 gram |
|---|
Be the first to review “Ruxolitinib”
Related products
Sale!
*Sales Promotion for 2022
Price range: $165.00 through $255.00
Sale!
*New Arrival
Price range: $50.00 through $700.00
Powder for Hairloss Treatment Research
Price range: $128.00 through $388.00
Sale!
*Sales Promotion for 2022
Price range: $100.00 through $1,000.00
Sale!
*Sales Promotion for 2022
Price range: $100.00 through $550.00
Powder for Hairloss Treatment Research
Price range: $168.00 through $268.00
New Research Chemicals
Price range: $500.00 through $3,000.00
*Sales Promotion for 2022
Price range: $120.00 through $700.00
Reviews
There are no reviews yet.